Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126259526 | 12625952 | 6 | F | 201607 | 20160818 | 20160805 | 20160829 | EXP | PHHY2016CA105784 | SANDOZ | 65.73 | YR | F | Y | 0.00000 | 20160829 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126259526 | 12625952 | 1 | SS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QMO | U | 0 | 300 | MG | INJECTION | /month | |||||
| 126259526 | 12625952 | 2 | SS | COSENTYX | SECUKINUMAB | 1 | U | 0 | INJECTION | ||||||||||
| 126259526 | 12625952 | 3 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG, QD | Y | 76859 | 2.5 | MG | QD | ||||||
| 126259526 | 12625952 | 4 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | Y | 0 | ||||||||||
| 126259526 | 12625952 | 5 | SS | VALSARTAN. | VALSARTAN | 1 | Unknown | 160 MG, QD | U | 0 | 160 | MG | DISPERSIBLE TABLET | QD | |||||
| 126259526 | 12625952 | 6 | C | PMS-ALENDRONATE | ALENDRONATE SODIUM | 1 | Unknown | 70 MG, QW | U | 0 | 70 | MG | /wk | ||||||
| 126259526 | 12625952 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0.5 DF, BID | U | 0 | .5 | DF | BID | ||||||
| 126259526 | 12625952 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, BID | U | 0 | 40 | MG | BID | ||||||
| 126259526 | 12625952 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 10000 IU, QW | U | 0 | 10000 | IU | /wk | ||||||
| 126259526 | 12625952 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 1.5 DF, QD (IN THE MORNING) | U | 0 | 1.5 | DF | QD | ||||||
| 126259526 | 12625952 | 11 | C | CORTEF//HYDROCORTISONE | 2 | Unknown | 2 DF, 1.5 IN MORNING AND 0.5 AT NIGHT | U | 0 | 2 | DF | ||||||||
| 126259526 | 12625952 | 12 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 126259526 | 12625952 | 13 | C | OXAZEPAM. | OXAZEPAM | 1 | Unknown | 10 MG, QD (AT BEDTIME) | U | 0 | 10 | MG | QD | ||||||
| 126259526 | 12625952 | 14 | C | PREGABALIN. | PREGABALIN | 1 | Unknown | 50 MG, DAILY AT BEDTIME | U | 0 | 50 | MG | QD | ||||||
| 126259526 | 12625952 | 15 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 2 DF, PRN (1 OR 2 TABLETS) | U | 0 | 2 | DF | |||||||
| 126259526 | 12625952 | 16 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK UKN, QID | U | 0 | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126259526 | 12625952 | 1 | Psoriasis |
| 126259526 | 12625952 | 2 | Psoriatic arthropathy |
| 126259526 | 12625952 | 3 | Hypertension |
| 126259526 | 12625952 | 4 | Product used for unknown indication |
| 126259526 | 12625952 | 5 | Product used for unknown indication |
| 126259526 | 12625952 | 6 | Product used for unknown indication |
| 126259526 | 12625952 | 7 | Product used for unknown indication |
| 126259526 | 12625952 | 8 | Product used for unknown indication |
| 126259526 | 12625952 | 9 | Product used for unknown indication |
| 126259526 | 12625952 | 10 | Product used for unknown indication |
| 126259526 | 12625952 | 11 | Product used for unknown indication |
| 126259526 | 12625952 | 12 | Product used for unknown indication |
| 126259526 | 12625952 | 13 | Product used for unknown indication |
| 126259526 | 12625952 | 14 | Product used for unknown indication |
| 126259526 | 12625952 | 15 | Product used for unknown indication |
| 126259526 | 12625952 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126259526 | 12625952 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126259526 | 12625952 | Cardiac failure | |
| 126259526 | 12625952 | Dyspnoea | |
| 126259526 | 12625952 | Fatigue | |
| 126259526 | 12625952 | General physical health deterioration | |
| 126259526 | 12625952 | Hypertension | |
| 126259526 | 12625952 | Peripheral swelling | |
| 126259526 | 12625952 | Pleural effusion | |
| 126259526 | 12625952 | Tachypnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126259526 | 12625952 | 1 | 20160704 | 0 | ||
| 126259526 | 12625952 | 3 | 20160725 | 0 | ||
| 126259526 | 12625952 | 4 | 200206 | 201509 | 0 |